<--- Back to Details
First PageDocument Content
Endometrial cancer / Endometrial stromal sarcoma / Ovarian cancer / Gynecologic oncology / Anastrozole / Estrogen receptor / European Society of Gynaecological Oncology / Gynaecological cancer / Medicine / Aromatase inhibitors
Date: 2014-09-01 00:48:56
Endometrial cancer
Endometrial stromal sarcoma
Ovarian cancer
Gynecologic oncology
Anastrozole
Estrogen receptor
European Society of Gynaecological Oncology
Gynaecological cancer
Medicine
Aromatase inhibitors

Add to Reading List

Source URL: gynae.anzgog.org.au

Download Document from Source Website

File Size: 302,33 KB

Share Document on Facebook

Similar Documents

Endometrial cancer (LUK) Kidney cancer (LUK) Pancreatic cancer Stomach cancer I)

Endometrial cancer (LUK) Kidney cancer (LUK) Pancreatic cancer Stomach cancer I)

DocID: 1uwW9 - View Document

2016 Issue 2  ON THE BRINK Jamie Bakkum-Gamez, M.D., is on a course to change

2016 Issue 2 ON THE BRINK Jamie Bakkum-Gamez, M.D., is on a course to change

DocID: 1qz5j - View Document

Microsoft Word - Fertile Hopes.docx

Microsoft Word - Fertile Hopes.docx

DocID: 1pMvw - View Document

OBESITY AND CANCER RISK Obesity is a condition in which a person has an abnormally high and unhealthy proportion of body fat. According to the Kansas Behavioral Risk Factor Surveillance System, in 2013, 30.0% of Kansas a

OBESITY AND CANCER RISK Obesity is a condition in which a person has an abnormally high and unhealthy proportion of body fat. According to the Kansas Behavioral Risk Factor Surveillance System, in 2013, 30.0% of Kansas a

DocID: 1pD2N - View Document

Microsoft Word - Consent ERA_inglés GB.docx

Microsoft Word - Consent ERA_inglés GB.docx

DocID: 1p4Nm - View Document